METRO I.V Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metro I.v, and when can generic versions of Metro I.v launch?
Metro I.v is a drug marketed by B Braun and is included in two NDAs.
The generic ingredient in METRO I.V is metronidazole. There are eighteen drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metro I.v
A generic version of METRO I.V was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for METRO I.V
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METRO I.V at DailyMed |
US Patents and Regulatory Information for METRO I.V
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | METRO I.V. | metronidazole | INJECTABLE;INJECTION | 018674-001 | Aug 31, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun | METRO I.V. IN PLASTIC CONTAINER | metronidazole | INJECTABLE;INJECTION | 018900-001 | Sep 29, 1983 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |